Regentys Miami, FL
The first non-surgical treatment option for Ulcerative Colitis.
Y1 (2015) Life SciencesOur companies have collectively raised nearly $1 billion in capital, with a unicorn and a publicly traded company among the ranks.
Sort by:
Showing 10 of 10 items
The first non-surgical treatment option for Ulcerative Colitis.
Y1 (2015) Life SciencesThe world’s first low-cost Human Papillomavirus (HPV) vaccine.
Y3 (2017) Life SciencesThe next generation of cancer therapies.
Y3 (2017) Life SciencesEmpowering health care innovation through data.
Y7 (2022) Health Life Sciences43North offers an opportunity to scale your business with funding and an immersive accelerator program. Each year, we invest $5 million into startups, offering founders a chance to secure $1 million in funding and gain access to a host of support services.
Breakthrough therapies for the treatment of blood diseases.
Y1 (2015) Life Sciences EXITWhere ideas become reality
Y1 (2015) Life SciencesA medical technology company focused on biosensor systems for life sciences.
Y1 (2015) Life SciencesWhat if we told you we could save one million lives every year with just refrigerator magnets and a laser pointer?
Y2 (2016) Life SciencesCytocybernetics is a Biotechnology which specializes in cellular electrophysiology.
Y2 (2016) Life SciencesTransform the experience of choosing clinical trials.
Y6 (2020) Health Life Sciences Healthcare Services